Sponsored ‘Top Docs’ show addresses Rx drug deactivation pouches
The latest edition of the Medical Association of Georgia’s (MAG) ‘Top Docs’ show was sponsored by Deterra Drug Deactivation and Disposal System, and it addresses the benefits of at-home drug deactivation pouches.
The episode features Chad Brummett, M.D., who is a professor and the senior associate chair for research with the Department of Anesthesiology at the University of Michigan.
Dr. Brummett discusses…
– Studies that he conducted that were featured in JAMA Surgery and JAMA Peditrics
– How drug deactivation pouches work, and how they’re unique
– The environmental benefits associated with drug deactivation pouches
– The FDA and EPA guidelines for flushing prescription drugs down the toilet
– Why patients keep prescription drugs once they’re no longer needed
– How many drug deactivation pouches a patient needs
– Co-dispensing drug deactivation pouches with opioid prescriptions
Dr. Brummett also serves as the co-director of the Michigan Opioid Prescribing Engagement Network (Michigan OPEN), which promotes good prescribing practices in the post-surgical, dental and emergency medicine fields. He has written articles that have appeared in more than 200 publications, including JAMA, JAMA Surgery, Anesthesiology, and the Annals of Surgery.
Deterra Drug Deactivation and Disposal System’s mission is to “prevent drug abuse and protect our environment through safe, permanent disposal of unused prescription and over the counter medications. The Deterra Drug Deactivation and Disposal System is the only product that is independently tested and scientifically proven to destroy drugs for good. [Its] patented, easy-to-use drug disposal system can be used at home or in a clinical setting to safely destroy unused or expired medications, making them unavailable for misuse and safe for disposal in the normal trash.” Contact Deterra Drug Deactivation and Disposal System at Sales@DeterraSystem.com or 612.568.1128.
Dr. Brummer is not affiliated with Deterra Drug Deactivation and Disposal System, nor did he receive any compensation from the company to conduct the study.
It is worth noting that MAG has policy that calls for the organization to “support the study, development, and public education of safe, effective, and cost-effective co-dispensed home drug deactivation products.”